Related Experiment Videos
Recurrent early ischemic events after thrombolysis for acute myocardial infarction
Insights
Patients with residual stenosis after acute myocardial infarction reperfusion face high ischemic event risk. Continued artery occlusion significantly reduces these risks, suggesting a need for definitive revascularization strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Research
Background:
- Myocardium salvaged by early thrombolysis with residual stenosis may be prone to subsequent ischemic events.
- Understanding short-term clinical outcomes is crucial for managing patients post-acute myocardial infarction (AMI).
Purpose of the Study:
- To investigate the incidence of recurrent ischemic events in patients after AMI treated with intracoronary thrombolysis.
- To compare clinical outcomes based on initial infarct artery status: subtotal occlusion, total occlusion with reperfusion, or continued occlusion.
Main Methods:
- Review of 81 consecutive patients from a randomized intracoronary thrombolysis trial.
- Coronary angiography within 5 hours of AMI symptom onset.
- Stratification into subtotal, reperfused, and occluded infarct artery groups.
Main Results:
- Recurrent ischemic events occurred in 65% of the subtotal group and 48% of the reperfused group.
- Significantly fewer events (11%) were observed in the occluded group (p < 0.01).
- Analysis of 1-vessel coronary artery disease (CAD) patients showed similar trends: 56% (subtotal), 30% (reperfused), and 10% (occluded).
Conclusions:
- Patients with residual stenosis after AMI reperfusion are at high risk for short-term ischemic events.
- Continued infarct artery occlusion is associated with a lower risk of recurrent ischemia.
- A more definitive revascularization strategy is suggested for acute myocardial infarction management.
Abstract:
Myocardium salvaged by early thrombolysis and then perfused through a residual stenosis may be at risk for ischemic events. To investigate this possibility, the short-term (2-week) clinical course of 81 consecutive patients managed within a randomized intracoronary thrombolysis trial was reviewed. All patients underwent coronary angiography within 5 hours of symptoms of acute myocardial infarction and were stratified into the following 3 outcome groups: patients with initially subtotal occlusion (subtotal group, n = 17), those with initial total occlusion and infarct artery reperfusion (reperfused group, n = 24) and those with continued infarct artery occlusion (occluded group, n = 40). Recurrent ischemic events were defined as spontaneous typical angina, provokable angina on predischarge exercise testing, and reinfarction. Eleven of 17 patients (65%) in the subtotal and 11 of 23 patients (48%) in the reperfused groups had an ischemic event (difference not significant). In contrast, 4 of 37 patients (11%) with occlusion had an ischemic event (p less than 0.01 compared with patients in the subtotal or reperfused groups). Four patients were excluded because of early (within 72 hours) elective coronary bypass surgery or death from pump failure. To eliminate the impact of multivessel coronary artery disease (CAD), 39 patients with 1-vessel CAD were analyzed separately. Five of 9 patients (56%) in the subtotal group, 3 of 10 (30%) in the reperfused group and only 2 of 20 (10%) in the occluded group had an ischemic event. These observations suggest the need for a more definitive revascularization strategy for acute myocardial infarction.